Literature DB >> 8690211

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts.

S Kargman1, S Charleson, M Cartwright, J Frank, D Riendeau, J Mancini, J Evans, G O'Neill.   

Abstract

BACKGROUND & AIMS: In the gastrointestinal tract, prostaglandins are implicated as important mediators of normal physiological processes. Prostaglandin G/H synthase (PGHS) is the first enzyme leading to the formation of prostaglandins. Two forms exist: the constitutive PGHS-1 and the inducible PGHS-2 isoforms. The purpose of this study was to examine the expression of PGHS-1 and -2 in gastrointestinal tissues.
METHODS: PGHS-1 and -2 expression and activity were examined in rat, dog, monkey, and human gastrointestinal tracts by immunoblot and biochemical assays.
RESULTS: PGHS-1 but not PGHS-2 protein was identified in all gastrointestinal tissues. PGHS-1 protein varied throughout the gastrointestinal tracts; interspecies differences were also noted. Immunohistochemical studies showed PGHS-1 staining of rat endothelial cells in all gastrointestinal regions; PGHS-2-specific staining was noted in a subset of macrophages in 3 of 22 rats examined. Elevated activity was shown in tissues expressing greater concentrations of PGHS-1 protein. Indomethacin, a nonsteroidal anti-inflammatory drug that inhibits both isoforms, inhibited prostaglandin synthesis, whereas NS-398, a selective PGHS-2 inhibitor, showed little or no inhibition of prostaglandin synthesis in gastrointestinal tissues.
CONCLUSIONS: These results indicate that prostaglandins produced in normal gastrointestinal tissue and required for normal physiological functioning are derived from the PGHS-1 isoform.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690211     DOI: 10.1053/gast.1996.v111.pm8690211

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  63 in total

Review 1.  Aspirin and other anti-inflammatory drugs.

Authors:  S J Vane
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs.

Authors:  Paul Dieppe; Christopher Bartlett; Peter Davey; Lesley Doyal; Shah Ebrahim
Journal:  BMJ       Date:  2004-07-03

3.  Lessons from the withdrawal of rofecoxib.

Authors:  Paul A Dieppe; Shah Ebrahim; Richard M Martin; Peter Jüni
Journal:  BMJ       Date:  2004-10-16

4.  Commonality of defensive roles of COX-2 in the lung and gut.

Authors:  John L Wallace
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

5.  Preconditioning stress prevents cold restraint stress-induced gastric lesions in rats: roles of COX-1, COX-2, and PLA2.

Authors:  Akiko Tanaka; Ryo Hatazawa; Yuka Takahira; Nahoko Izumi; Ludmila Filaretova; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

6.  Low-level laser therapy modulates cyclo-oxygenase-2 expression during bone repair in rats.

Authors:  Mariza A Matsumoto; Rafael V Ferino; Giovanni F Monteleone; Daniel A Ribeiro
Journal:  Lasers Med Sci       Date:  2008-02-29       Impact factor: 3.161

7.  Short-term administration of non-selective and selective COX-2 NSAIDs do not interfere with bone repair in rats.

Authors:  Mariza Akemi Matsumoto; Angelita De Oliveira; Paulo Domingos Ribeiro Junior; Hugo Nary Filho; Daniel Araki Ribeiro
Journal:  J Mol Histol       Date:  2008-07-01       Impact factor: 2.611

8.  Model-based prediction of the acute and long-term safety profile of naproxen in rats.

Authors:  Tarjinder Sahota; Ian Sanderson; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Pharmacol       Date:  2015-06-29       Impact factor: 8.739

9.  Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats.

Authors:  Ana Paula Ribeiro Paiotti; Daniel Araki Ribeiro; Roseane Mendes Silva; Patrícia Marchi; Celina Tizuko Fujiyama Oshima; Ricardo Artigiani Neto; Sender Jankiel Miszputen; Marcello Franco
Journal:  J Mol Histol       Date:  2012-03-20       Impact factor: 2.611

10.  Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling.

Authors:  Suresh Guruswamy; Chinthalapally V Rao
Journal:  Gene Regul Syst Bio       Date:  2008-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.